What is Fahr disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fahr's Disease

Fahr's disease is a rare neurological disorder characterized by abnormal calcified deposits in the basal ganglia, dentate nuclei of the cerebellum, and cerebral cortex, leading to progressive neurological dysfunction. 1

Clinical Characteristics

Pathophysiology

  • Abnormal calcium deposits (calcium carbonate and calcium phosphate) primarily affect:
    • Basal ganglia
    • Thalamus
    • Hippocampus
    • Cerebral cortex
    • Cerebellar subcortical white matter
    • Dentate nucleus 1

Demographics

  • Typically affects young to middle-aged adults 1
  • Can present late in life, with cases reported in elderly patients 2

Clinical Manifestations

Fahr's disease presents with a wide spectrum of symptoms:

  1. Neurological symptoms:

    • Movement disorders including Parkinsonism, chorea, and tremors
    • Dystonia
    • Ataxia
    • Seizures
    • Impaired eye movements 1, 2
  2. Neuropsychiatric manifestations:

    • Memory and concentration deficits
    • Dementia
    • Behavioral abnormalities
    • Psychosis and hallucinations
    • Confusion and altered mental status 3, 4, 2
  3. Other presentations:

    • Speech abnormalities
    • Gait disturbances 4

Diagnostic Criteria

The diagnosis of Fahr's disease is based on the following criteria:

  1. Bilateral calcification of basal ganglia
  2. Progressive neurologic dysfunction
  3. Absence of biochemical abnormalities
  4. Absence of infectious, traumatic, or toxic causes
  5. Significant family history 1

Diagnostic Imaging

  • CT scan: Most sensitive for detecting calcifications; shows extensive bilateral calcifications in the basal ganglia, dentate nuclei, and subcortical white matter
  • MRI: Complementary to CT but less sensitive for calcifications
  • Plain radiography: May show calcifications but less sensitive than CT 1, 4

Laboratory Investigations

  • Complete blood count
  • Serum calcium, phosphorus, alkaline phosphatase
  • Parathyroid hormone levels (to rule out hypoparathyroidism)
  • Thyroid function tests
  • Cerebrospinal fluid analysis (if indicated) 1, 5

Differential Diagnosis

Important to distinguish from secondary causes of brain calcification:

  • Hypoparathyroidism and pseudohypoparathyroidism
  • Endocrine disorders
  • Mitochondrial myopathies
  • Infectious diseases
  • Toxic exposures 1, 5

Management

Currently, there is no specific cure for Fahr's disease. Management focuses on:

  1. Symptomatic treatment:

    • Movement disorders: Appropriate medications based on specific symptoms
    • Psychiatric symptoms: Antipsychotics, antidepressants as needed
    • Seizures: Anticonvulsants if present 1
  2. Treatment of underlying causes:

    • If secondary to hypoparathyroidism: Calcium and vitamin D supplementation 5
  3. Supportive care:

    • Physical therapy for movement disorders
    • Cognitive rehabilitation for cognitive impairment
    • Psychological support 1

Prognosis

  • The disease is progressive with variable rates of deterioration
  • Some evidence suggests early diagnosis and treatment of underlying causes (if present) may reverse calcification and improve mental function 1

Genetic Counseling

  • Families with known history of Fahr's disease should receive genetic counseling
  • The disease may have autosomal dominant or recessive inheritance patterns
  • Molecular genetics of this disease have not been extensively studied 1, 4

Key Clinical Considerations

  • Consider Fahr's disease in patients presenting with unexplained movement disorders and/or neuropsychiatric symptoms
  • Brain imaging is essential for diagnosis when clinical suspicion exists
  • Always rule out secondary causes of brain calcification, particularly endocrine disorders like hypoparathyroidism
  • Early diagnosis may lead to better management of symptoms and potentially slow disease progression 1, 3, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.